Introduction
============

Zika virus (ZIKV), is a mosquito-borne virus that belongs to *Flavivirus* genus of the *Flaviviridae* family, which includes other members, namely dengue virus (DENV), yellow fever virus (YFV), West Nile virus (WNV), Japanese encephalitis virus (JEV), and tick-borne encephalitis virus (TBEV) ([@B55]; [@B27]). ZIKV is a positive-sense single-stranded RNA virus with an approximately 10.7 kb genome encoding 3,419 aa or a single polyprotein that is cleaved post-translationally by host and viral proteases into 3 structural proteins; i.e., capsid (C), pre-membrane (prM), and envelope (E), and 7 non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) ([@B39]).

During the recent large outbreak in Brazil, ZIKV emerged as an infectious agent ([@B75]) affecting the fetal brain development causing severe deformities, and sometimes death (before or shortly after birth) ([@B18]). It appears that ZIKV mutated during the earlier outbreak in French Polynesia, where, retrospective study revealed association between microcephaly and virus infection ([@B12]). Targeting the fetus was the major feature of this epidemic, since, ZIKV or other known flaviviruses have never been previously associated with fetal abnormalities ([@B58]; [@B76]). It appears that ZIKV selectively infects progenitor cells, while leaving differentiated cells unaffected ([@B84]). However, in pregnant women, ZIKV crosses placenta and infects fetus brain, which presents as microcephaly (a smaller than normal head) in newborns ([@B70]; [@B16]). Also, cases of stillbirth due to ZIKV infection have been reported ([@B46]; [@B69]; [@B77]).

Zika virus infection in adults is mild and self-limiting and, often, infected individuals do not seek any medical attention ([@B21]). Symptomatic ZIKV infection is characterized by fatigue, rash, headache, exanthema, fever, arthralgia, myalgia and conjunctivitis ([@B13]). Exanthema is the most prominent sign of infection in majority of the documented cases, and symptoms usually resolve within 2 weeks without post-morbid sequelae ([@B13]). In some patients, however, severe neurological complications are diagnosed, including meningitis, meningoencephalitis, and Guillain-Barre syndrome (GBS) ([@B82]). GBS is rare but serious autoimmune disease targeting nerves ([@B10]). GBS is the most often diagnosed neurological sequelae in ZIKV-infected individuals. Interestingly, the higher incidence of GBS was diagnosed in older population, which makes this group of patients particularly vulnerable to post-ZIKV infection neurological complications.

Modes of ZIKV Transmission
==========================

Zika virus is transmitted by *Aedes* species mosquitoes, primarily *Aedes albopictus, and Aedes aegypti*. There is a close relationship between the host and mosquito vector, where mosquitoes become infected while feeding off the host blood and pass the virus to the next host during the blood meal process ([@B65]). Indian territory is a natural habitat for invasive *Aedes* mosquitoes which are widely distributed throughout the country ([@B36]). The *Aedes albopictus* carrying ZIKV, is the most invasive species and spread rapidly in many countries of the Old and New Worlds ([@B43]). The unique ability of *Aedes albopictus* to propagate in the wild as well as near human settlements was essential for establishing presence of this vector in new areas ([@B53]). The *Aedes albopictus*, which is ubiquitously present throughout the year in India, is however, more often associated as the vector for DENV transmission ([@B38]). Primarily *Aedes aegypti* is screened for ZIKV in India but more studies are required to evaluate the role of other *Aedes* species currently in circulation of ZIKV in India.

In addition to *Aedes*, other mosquito species, including *Anopheles*, *Culex*, *Eretmapodites*, and *Mansonia* could also transmit the virus ([@B32]; [@B47]; [@B30]). More recently, according to two controversial reports from China and Brazil, *Culex Quinquefasciatus* has been reported to transmit the ZIKV ([@B32]; [@B30]). The *Culex Quinquefasciatus* is also widespread across India, similar to the *Aedes* species ([@B50]; [@B4]) and in some regions of India, up to 96% of all mosquito bites were from *Culex* ([@B50]). Like *Aedes species, Culex* mosquitoes also propagate near human dwellings and are found in overflow water from houses, ground pools, ditches and shallow wells ([@B5]). *Culex* is considered as an opportunistic feeder, as in addition to humans, it could also feed off pigs, cows and birds ([@B14]). Therefore, the role of Culex in ZIKV transmission to human was extensively studied in laboratory and field collected mosquitoes. Results of vector competence study have demonstrated that *C quinquefasciatus* is poor ZIKV transmitter and, therefore, it is unlikely to contribute to virus epidemiology ([@B1]; [@B25]; [@B31]; [@B80]). As a conclusion, *Aedes* species are accepted now as the main carriers of ZIKV, population control as well as positivity for ZIKV antigens of these two species could serve as a predictor of the future outbreaks.

It is accepted that vector control is essential for prevention of mosquito-borne infections. Elimination of the adult mosquitoes is usually not the most effective vector control approach. Instead, targeting larvae by eliminating or cleaning the water-holding reservoirs around the houses has been shown as an effective way to significantly reduce the mosquitoes population ([@B29]; [@B62]). This approach was successfully used earlier to control the spread of mosquito-borne DENV infections ([@B37]).

However, it appears that arthropod control should be maintained continuously as mosquitoes can quickly re-populate territories once the use of insecticides is discontinued. ([@B37]). Also, mosquitoes can develop resistance to insecticides. Studies have shown that *Culex* species mosquitoes have developed resistance to commonly used insecticides that has hampered the efforts to reduce mosquito population ([@B57]). The resistance to a variety of insecticides may increase the risk of ZIKV spread into the new territories. Therefore, it appears that use of insecticide approach may not be the best to achieve the reduction of mosquito population. It has been suggested that community-based strategies to reduce the larval sources will be the cost-effective and more sustainable approach. This approach requires community education, where people living in areas populated by *Aedes* mosquitoes become aware of potential health hazards and have access to programs providing education on larval habitat control.

A novel, genetics-based vector control is focused on genetic modification of mosquitoes to decrease their propagation capability (recently reviewed by [@B41]). Multiple approaches were developed including mosquito gene editing using CRISPR/Cas9 ([@B26]), homing gene drives ([@B81]), meiotic drive and sex distortion ([@B8]) and many others (recently reviewed by [@B34]). These approaches provide the most targeted and cost-effective interventions, which could be used as complementary to existing preventive measures. As much as exciting these technologies are, concerns about dissemination of genetic modifications across various species was expressed by scientific community ([@B35]). Also, potential negative impact on the natural ecosystem should be considered. The high likelihood of serious consequences requires careful approach for implementing genetics-based vector control including informed consent from governments and regulators as well as the local communities. Therefore, education of government and communities is essential for successful implementation of gene base control of mosquito.

Historical Overview of ZIKV in India
====================================

It is believed that ZIKV reached Asia in 1970s, when cases were documented in Pakistan and Indonesia ([@B52]; [@B17]). However, a research study by [@B71] suggests that ZIKV was already circulating in the region as ZIKV neutralizing antibodies were detected in healthy donor serum in 1952. This study utilized serum samples collected in 1952, which is 5 years after isolation of ZIKV in Uganda, Africa ([@B20]). These findings bring up a possibility of ZIKV spreading far distance from the site of origin before it was even first isolated in Africa. In 1954 study of ZIKV antibody prevalence in Indian population, a total of 588 serum samples were collected from donors residing in 38 widely scattered locations ([@B71]; **Figure [1](#F1){ref-type="fig"}**), while 196 samples were tested for presence of anti-ZIKV neutralizing antibodies. Selection of the sites for the blood collection was made to cover the large geographic area as well as to include locations with high rainfall or forest, which could affect the epidemiology of arthropod-borne virus infection. To ensure that seroprevalence is strictly associated with local infection, individuals traveling any great distances were excluded. Neutralizing antibodies were detected in 33 serum samples out of 196 tested (16.8%). ZIKV seropositive donors were detected in many locations, including those near Bombay (Broach district; 7 of 17 immune), Saurashtra (Sorath district; 4 of 11 protective), Madhya Pradesh (Nagpur district; 7 of 15 protective), Hyderabad and Madras (**Figure [1](#F1){ref-type="fig"}**). It appears that there are several locations with high seropositivity rate including Bareja and Nagpur. Interestingly, authors state that the single site showing the highest rate of seropositivity was Bareja, which is located in the Ahmedabad district. The same site, the Ahmedabad city, is where ZIKV positive samples were recently reported by [@B68]. Therefore, it could be suggested that ZIKV was circulating in this region for more than 6 decades, without association with major outbreaks. It was an interesting observation that presence of ZIKV neutralizing antibodies was not associated with protection against any other viruses included in the study by Smithburn et al. ([@B20]). Therefore, authors conclude that seropositivity is most likely associated with infection with ZIKV and is not a result of cross-reactivity.
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ZIKV Genotype in India
======================

First ZIKV strain was isolated in 1947 from sentinel monkey in the Zika forest in Uganda, Africa ([@B20]). Only sporadic cases of ZIKV infection were reported in following 6 decades ([@B54]). Two ZIKV outbreaks, in 2007 and 2013, announced the new era in virus epidemiology ([@B21]; [@B64]). These outbreaks are characterized by a large number of symptomatic cases and rapid spread of ZIKV across the Pacific Ocean islands reaching South America ([@B64]; [@B22]; [@B74]). Genetic analysis revealed that ZIKV evolved rapidly undergoing multiple nucleotide changes in viral RNA have accumulated over time between 1947 and 2007 ([@B78]). Interestingly, it appears that numerous changes in virus genome occurred during the period of "epidemiological silence," when only a few cases of ZIKV infection were documented around the world. Many new strains were identified, comprising two major lineages: African and Asian (including South American) ([@B28]). The Asian lineage prototype was isolated from *A. aegypti* mosquitoes collected in Malaysia in 1966 ([@B44]; [@B78]), and it is the lineage currently associated with microcephaly ([@B67]).

Zika virus sequences obtained from Ahmedabad, India, cases revealed their close relationship to Asian strains ([@B68]). Interestingly, there is a possible connection between Indian cases from 2017 and ZIKV seropositivity reports from Pakistan in 1983 ([@B17]). In a study of Darwish et al. ZIKV antibody was detected in animal and human samples collected from several sites in Pakistan including Karachi, Sind, Baluchistan and Punjab Provinces ([@B17]; **Figure [1](#F1){ref-type="fig"}**). Two sites, Karachi and Punjab province in Pakistan are in close proximity to the Indian border, while Karachi is near Ahmedabad, India. ZIKV's association with microcephaly and GBS during the recent outbreak prompted investigations on circulation of the virus in Bangladesh, country neighboring India (**Figure [1](#F1){ref-type="fig"}**). One serum sample was found positive for ZIKV RNA when 200 samples collected at various locations in Bangladesh were analyzed ([@B51]). Phylogenetic analysis revealed that this sample clusters together with "Asian lineage" of ZIKV. Interestingly, the same, "Asian lineage" ZIKV was identified in Ahmedabad, India by [@B68]. ZIKV positive sample was obtained from individual who never traveled outside of the region or internationally, suggesting that infection occurred locally. Taken together, these data indicates that "Asian lineage" ZIKV is the main strain circulating in this region and is associated with human infections.

Zika virus surveillance study in Pakistan revealed that many animals were also seropositive for ZIKV, suggesting that different hosts, besides human, could be involved in ZIKV circulation in this region ([@B17]). Also, domestic animals, for e.g., sheep and goat, were also found seropositive for ZIKV. It could be suggested that *Culex* mosquitoes are passing ZIKV to the livestocks, as it has been shown to feed off pigs, sheep and birds. On the contrary, the *Aedes* feed predominantly on humans (24%), cats (21%), dogs (14%), and birds (7%). These observations point out the importance of *Aedes* and *Culex* mosquitoes control.

Challenges of ZIKV Diagnostics and Treatment
============================================

The Asian lineage of ZIKV is characterized by mild form of infection, with symptoms mainly including skin rashes, fever and signs of inflammation. Interestingly, fever of unknown etiology is common diagnosis in the rural hospitals in India and Pakistan. Limited access to clinical diagnostics hampers identification of infectious agent making many ZIKV cases remain undetected. This brings to attention the necessity of simple and low-cost diagnostics for ZIKV infection in the region. These diagnostics should be simple in use and require less complex and expensive equipment. One of the tests which could fit the requirements is the lateral flow immunoassay (LFI), often referred to as "dip stick." LFI combines unique advantages of bio-recognition probes and chromatography, where results are evaluated visually. Variety of samples could be used for LFI, including, urine, serum, plasma, and saliva ([@B42]; [@B11]; [@B49]). LFI diagnostics have long shelf life, use small quantity of sample and do not require refrigeration, which makes them well adapted for use in rural areas. Multiple strategies were applied to develop LFI based diagnostics ([@B40]; [@B2]; [@B15]), still more research is required to identify the test which would be specific, easy to use and inexpensive.

Zika virus diagnostics is challenging because of extensive antibody cross-reactivity against related flaviviruses, e.g., DENV ([@B9]). Serum from ZIKV-infected patients and ZIKV/DENV-co-infected individuals reacted with envelope (E) and non-structural 1 (NS1) proteins of ZIKV as well as DENV ([@B72]). The E, pre-membrane (prM), and the NS1 proteins are the main antigens associated with targets for human B-cell responses in DENV infections ([@B59]; [@B72]). It is believed that considerable structural and genetic similarities between ZIKV and DENV are responsible for observed antibody cross-reactivity between these closely related viruses. The E protein binds to the receptor triggering viral entry; therefore, it is a major target for neutralizing antibody responses ([@B73]). Cross-reactive antibodies can be protective, as they can interfere with virus binding to the receptor and entering the cell. However, these antibodies could also exacerbate the disease by increasing the rate of infection ([@B33]). This effect was explained by antibody-dependent enhancement (ADE, [@B66]), where cross-reacting antibodies form immune complexes with the antigen. These complexes are more efficiently taken up by leukocytes *via* Fc-receptors ([@B33]). ADE has been shown between antibodies against DENV and ZIKV ([@B19]; [@B59]). These studies are important in the view that India is also endemic for DENV, therefore, it could be suggested that cross-reactivity between antibodies to ZIKV and DENV could promote virus spread and contribute to ZIKV epidemics. However, there is still lack of evidence that ADE contributes to ZIKV epidemics ([@B45]). Nanopore based sequencing technology is a novel powerful tool for detection of viruses directly from clinical samples ([@B61]). This sequencing approach does not require isolation and culturing the virus, yet it provides sufficient number of reads to identify the infectious agent in as small number of copies as 50 genomes per reaction. Data analysis is based on simple to follow protocol and it could be done in remote areas with limited access to the internet for the analysis. The multi-fold genome coverage allows the MinION nanopore sequencing to reach over 99% accuracy of the post-data analysis, which is sufficient for accurate detection of known viruses ([@B79]). This technology was successfully used for detection of multiple arboviruses including DENV, ZIKV, and Venezuelan Equine Encephalitis Virus ([@B48]; [@B61]; [@B66]).

Presently, there is no effective treatment or vaccine for ZIKV infection. Therapy is mainly supportive and includes fluid and pain management. Prevention includes mosquito bite control including personal protection. Caution is advised to pregnant women traveling to ZIKV endemic countries. Testing should be available to those traveling to endemic countries; special attention should be given to pregnant women and individuals with fever and skin rash. It is essential to conduct thorough examination of the fetus for early diagnosis of brain deformities.

Will ZIKV Microcephaly Ever Be Diagnosed in India?
==================================================

As reported, ZIKV epidemiology began in Africa, when the first strain of virus, was isolated in Uganda (African lineage; 1947) ([@B20]). Later, ZIKV seroconversion was documented in Asia (Asian lineage; 1966), followed by outbreaks in Pacific Islands (Asian lineage; 2007) and South America (Asian/American lineage; early 2015) ([@B56]). Crossing of the Pacific Ocean and invasion of South America has been associated with dramatic changes in clinical manifestation of ZIKV infection, as for the first time, severe neurological disorders, such as congenital ZIKV syndrome (microcephaly and other developmental defects in neonatal brain) are now linked to ZIKV pathogenesis ([@B18]). It appears that over years, a lesser-known ZIKV that left Zika forest in Uganda has dramatically evolved from a mild-disease causing virus to potentially a more-virulent and deadly virus. Whether the new contemporary epidemic ZIKV strain belonging to Asian/American lineage will remain in Americas or continue traveling across several countries to finally return to the land of its origin, still remains unclear.

In this regards, periodic imported cases of ZIKV infection due to South American strains of ZIKV have already been documented in Europe ([@B3]; [@B24]; [@B83]; [@B60]; [@B7]; **Figure [2](#F2){ref-type="fig"}**). According to the European Center for Disease Prevention and Control (ECDC), invasive ZIKV-vectors, including *Aedes aegypti* and *Aedes albopictus* have been reported in several European countries, including Austria, Bosnia, France, Germany, and Italy ([@B23]). In addition, though the reported ZIKV imported cases are all travel-associated cases, the *Aedes* mosquitoes in the natural reservoirs could potentially become infected while feeding off the viremic ZIKV-infected individuals and spread the infection across the resident population. It has also been suggested that the climate change as well as human activities can contribute to *Aedes* species spread into the nearby territories and establish new sustainable populations ([@B23]). As these species are most substantial vectors of ZIKV transmission to humans, it could be suggested that requirements for ZIKV outbreak are now present in Europe. Introducing the new contemporary ZIKV Asian/American strain into *Aedes* population in Europe may also cause newborn microcephaly and neurological complications due to ZIKV infection. As [@B63] has shown, travel from ZIKV endemic regions of the Americas aligns with peak predicted capacity of *Aedes* vectors to transmit infection. Europe is in close proximity to Africa and has close commercial and historic ties with many African countries. Therefore, there is a potential threat that now ZIKV, targeting the fetus brain, can cause outrageous epidemics in Africa, and subsequently spread throughout Asia. In addition, due to a combination of factors, including visitors infected with ZIKV, weak cross-border surveillance, climate change, and lack of effective vector control measures, India and neighboring countries (Pakistan and Bangladesh) are pre-disposed to ZIKV importation and epidemics in the near future, causing a potential public health concern ([@B6]). A close global monitoring of ZIKV epidemiology is therefore required to predict ZIKV outbreaks caused by new contemporary virulent ZIKV strain.
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